Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Teikoku Seiyaku Co. Ltd. currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner. The portfolio is active in 1 distinct art unit, which suggests a specific focus for the current prosecution cycle, as there is no distribution of work across different technical groups. This concentration allows for a unified prosecution strategy but limits the diversity of examiner perspectives.
WARD, PAUL V is identified as the busiest examiner for the company. This individual is responsible for 1 busiest examiner pending office action. The alignment between the total pending actions and the workload of this specific examiner indicates that all current activity is centralized under a single point of review. This centralization means the company's immediate patent strategy in this technology area depends entirely on the findings of WARD, PAUL V. Practitioners should focus on the specific preferences of this individual to anticipate the outcome of the 1 pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WARD, PAUL V | 1 | 83.2% | -12.2% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18279718 | LOXOPROFEN-CONTAINING ADHESIVE PATCH AND METHOD FOR MANUFACTURING SAME | WARD, PAUL V | — |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18279718 | LOXOPROFEN-CONTAINING ADHESIVE PATCH AND METHOD FOR MANUFACTURING SAME | WARD, PAUL V | 1622 | §103 | Non-Final OA | — | Pending | Aug 31, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial